Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 24;12(8):e0183027.
doi: 10.1371/journal.pone.0183027. eCollection 2017.

NAMPT serum levels are selectively elevated in acute infectious disease and in acute relapse of chronic inflammatory diseases in children

Julia Gesing  1 , Kathrin Scheuermann  1   2 , Isabel Viola Wagner  3 , Dennis Löffler  4 , Daniela Friebe  1 , Wieland Kiess  1   2 , Volker Schuster  1 , Antje Körner  1   2
Affiliations

NAMPT serum levels are selectively elevated in acute infectious disease and in acute relapse of chronic inflammatory diseases in children

Julia Gesing et al. PLoS One. .

Abstract

Nicotinamide phosphoribosyl transferase (NAMPT) is an inflammatory adipocytokine shown to interact in immune modulation in chronic inflammatory diseases, acute respiratory distress syndrome, sepsis, cancer and obesity in adulthood. It is, however, not clear whether this association reflects a chronic elevation or acute inflammatory response. We analyzed NAMPT concentrations in distinct states of inflammation in 102 children and found consistently significantly increased NAMPT levels in subjects with acute infections. NAMPT concentrations in children with stable chronic inflammatory diseases were not significantly different, whereas in patients with acute relapse of chronic disease NAMPT was significantly higher than in children in remission or healthy controls. In states of low-grade inflammation (children with atopic disease or obesity) we did not detect alterations in NAMPT serum levels. NAMPT correlated positively with inflammatory markers such as CRP. The most predictive factor for NAMPT serum concentrations was leucocyte count and therein the neutrophil count. Furthermore, systemic circulating NAMPT levels were closely associated with NAMPT release from corresponding cultured PBMCs. In conclusion, NAMPT is selectively increased in states of acute but not chronic inflammation in children. The close relationship between systemic circulating NAMPT with leucocyte counts and release indicate that leucocytes most probably are the source of inflammation related NAMPT levels.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. NAMPT serum concentrations in distinct inflammatory conditions.
Comparison of NAMPT concentrations between patient groups of distinct inflammatory conditions and controls (A). Patients with chronic inflammation were further stratified into patients with active disease vs. patients without symptoms (remission) (B). Boxes are interquartile range, whiskers are minimum to maximum. Statistical significance was assessed by ANOVA and Tukey HSD test in log transformed values.
Fig 2
Fig 2. Positive correlation between NAMPT serum levels and inflammatory markers.
Correlation between log NAMPT serum concentration and log C-reactive protein (A), log ESR (1 hour) (B), log leucocyte count(C) and log neutrophil granulocyte count (D).
Fig 3
Fig 3. NAMPT release from PBMCs.
Comparison of NAMPT release between patient groups of distinct inflammatory conditions and controls (A). Boxes are interquartile range, whiskers are minimum to maximum. Statistical significance was assessed by ANOVA and Tukey HSD test. Correlation between log NAMPT serum concentrations and corresponding NAMPT release from PBMCs of the same patient (B) and Correlation between NAMPT release from PBMCs with blood neutrophil counts (C).
See this image and copyright information in PMC

References

    1. Montecucco F, Cea M, Cagnetta A, Damonte P, Nahimana A, Ballestrero A, et al. Nicotinamide phosphoribosyltransferase as a target in inflammation-related disorders. Curr Top Med Chem. 2013;13: 2930–2938. - PubMed
    1. Garten A, Petzold S, Schuster S, Körner A, Kratzsch J, Kiess W. Nampt and its potential role in inflammation and type 2 diabetes. Handb. Exp. Pharmacol. 2011;147–164. doi: 10.1007/978-3-642-17214-4_7 - DOI - PubMed
    1. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994;14(2): 1431–1437. - PMC - PubMed
    1. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur.J Immunol. 2002;32(11): 3225–3234. doi: 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L - DOI - PubMed
    1. Zhang LQ, Van Haandel L, Xiong M, Huang P, Heruth DP, Bi C, et al. Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase. Cell Death Dis. 2017;23;8(3): e2705 doi: 10.1038/cddis.2017.132 - DOI - PMC - PubMed

Substances